Invest Daily Pro
  • Economy
  • Investing
No Result
View All Result
  • Economy
  • Investing
No Result
View All Result
Invest Daily Pro
No Result
View All Result
Home Economy

ZEISS Group sees positive outcome with strong revenue growth

by
December 18, 2024
in Economy, Investing
0
ZEISS Group sees positive outcome with strong revenue growth
0
SHARES
9
VIEWS
Share on FacebookShare on Twitter

ZEISS Group’s annual revenue for the fiscal year 2023/24 has reached an impressive 10.894 billion euros, marking an 8% increase from the previous year. Despite this growth, the company’s earnings before interest and taxes (EBIT) decreased to 1.444 billion euros from 1.686 billion euros in the prior year, resulting in an EBIT margin of 13%.

The company’s four segments, namely Semiconductor Manufacturing Technology, Industrial Quality & Research, Medical Technology, and Consumer Markets, all contributed to the overall revenue growth. However, the segments were impacted to varying degrees by the increasingly challenging market environment, including geopolitical tensions and a weaker global economy.

Dr. Karl Lamprecht, President and CEO of ZEISS, expressed satisfaction with the company’s performance in the past fiscal year, stating, “Overall, we ended fiscal year 2023/24 with a good result and revenue growth. At the same time, it was not possible for all areas to escape the impact of current developments on the global markets.”

In order to maintain its success, ZEISS has invested a record 15% of its revenue in research and development, the highest amount in the company’s history. They have also focused on expanding their personnel and infrastructure.

The Semiconductor Manufacturing Technology segment saw the highest growth, with a 16% increase in revenue. In contrast, the Industrial Quality & Research, Medical Technology, and Consumer Markets segments reported a 3-4% growth, adjusted for currency effects.

Looking ahead, ZEISS acknowledges the need to reinforce resilience measures in light of the challenging market environment for the direct-to-market segments. However, with its strong innovative capabilities and investments in research and development, the company remains confident in its ability to navigate these challenges and continue its growth trajectory.

ShareTweetPin

Related Posts

Top 3 Small-cap Medical Device Stocks (Updated January 2026)
Investing

Top 3 Small-cap Medical Device Stocks (Updated January 2026)

January 7, 2026
Top 3 Small-cap Medical Device Stocks (Updated January 2026)
Investing

Top 3 Small-cap Medical Device Stocks (Updated January 2026)

January 7, 2026
Prismo Metals Announces Assay & IP Survey Results at Silver King
Investing

Prismo Metals Announces Assay & IP Survey Results at Silver King

January 7, 2026
Prismo Metals Announces Assay & IP Survey Results at Silver King
Investing

Prismo Metals Announces Assay & IP Survey Results at Silver King

January 7, 2026
5 Best-performing Canadian Pharma Stocks (Updated January 2026)
Investing

5 Best-performing Canadian Pharma Stocks (Updated January 2026)

January 6, 2026
Centurion Minerals
Investing

Centurion Minerals

January 6, 2026
Next Post
Shapeways Enhances Creator Ecosystem with Majority Acquisition of Thangs

Shapeways Enhances Creator Ecosystem with Majority Acquisition of Thangs

Recommended

Loose Women’s Kaye Adams prevails in ten-year battle with HMRC over IR35 tax dispute

Loose Women’s Kaye Adams prevails in ten-year battle with HMRC over IR35 tax dispute

November 7, 2024
Save Big on Refurbished Tech with Wisetek Market EU’s Black Friday Deals

Save Big on Refurbished Tech with Wisetek Market EU’s Black Friday Deals

November 27, 2024
What is Tokenization and How Can it Benefit Businesses?

What is Tokenization and How Can it Benefit Businesses?

August 18, 2024
John Lewis CEO criticises Rachel Reeves over ‘two-handed’ tax increase

John Lewis CEO criticises Rachel Reeves over ‘two-handed’ tax increase

November 21, 2024
Zweig Breadth Thrust Dominates the Headlines – But What about an Exit Strategy?

Zweig Breadth Thrust Dominates the Headlines – But What about an Exit Strategy?

April 27, 2025
Arts & Culture (09/11/24)

Arts & Culture (09/11/24)

September 10, 2024

    Stay updated with the latest news, exclusive offers, and special promotions. Sign up now and be the first to know! As a member, you'll receive curated content, insider tips, and invitations to exclusive events. Don't miss out on being part of something special.


    By opting in you agree to receive emails from us and our affiliates. Your information is secure and your privacy is protected.

    Top 3 Small-cap Medical Device Stocks (Updated January 2026)

    Top 3 Small-cap Medical Device Stocks (Updated January 2026)

    January 7, 2026
    Top 3 Small-cap Medical Device Stocks (Updated January 2026)

    Top 3 Small-cap Medical Device Stocks (Updated January 2026)

    January 7, 2026
    Prismo Metals Announces Assay & IP Survey Results at Silver King

    Prismo Metals Announces Assay & IP Survey Results at Silver King

    January 7, 2026
    • About us
    • Contact us
    • Privacy Policy
    • Terms & Conditions

    Copyright © 2026 investdailypro.com | All Rights Reserved

    No Result
    View All Result
    • About us
    • Contact us
    • Home
    • Privacy Policy
    • Suspicious engagement
    • Terms & Conditions
    • Thank you

    Copyright © 2026 investdailypro.com | All Rights Reserved